How does ivabradine affect CHF patients with comorbidities?

In a recent webinar, Professor Martin Cowie, Professor of Cardiology, Imperial College London (Royal Brompton Hospital), outlined the SHIFT study findings for ivabradine in Chronic Heart Failure. Here, he shares the data on patient subgroups, including those with a heart rate over 77 bpm, and patients with comorbidities – i.e. our commonly seen real-world patients.